CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-22 | KINGSLEY ALFRED D Director | Option exercise | +61,800 | $2.20 | $136K | 5,470,245 |
| 2021-06-22 | KINGSLEY ALFRED D Director | Option exercise · Stock Option (right to buy) | −61,800 | 0 | ||
| 2021-06-21 | Cook Kevin Leon Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2021-06-18 | Mulroy Michael H. Director | Option exercise | +24,720 | $2.20 | $54K | 251,555 |
| 2021-06-18 | Mulroy Michael H. Director | Option exercise · Stock Option (right to buy) | −24,720 | 0 | ||
| 2021-05-04 | Jayasuriya Anula Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2021-04-20 | Amin Dipti Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2021-03-31 | Culley Brian M President and CEO | Option exercise | +15,450 | $2.35 | $36K | 201,052 |
| 2021-03-31 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $2.35 | $13K | 195,709 |
| 2021-03-31 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 77,250 | ||
| 2021-03-30 | Hernandez Alexandra Sr Director Finance/Controller | Option exercise | +6,000 | $0.69 | $4K | 6,000 |
| 2021-03-30 | Hernandez Alexandra Sr Director Finance/Controller | Sale | −6,000 | $2.23 | $13K | 0 |
| 2021-03-30 | Hernandez Alexandra Sr Director Finance/Controller | Option exercise · Employee Stock Option (Right to Buy) | −6,000 | 39,200 | ||
| 2021-03-15 | Hernandez Alexandra Sr Director Finance/Controller | Grant or award · Employee Stock Option (Right to Buy) | +42,700 | 42,700 | ||
| 2021-03-15 | Culley Brian M President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,165,100 | 1,165,100 | ||
| 2021-03-15 | Leavitt Chase C. General Counsel/Secretary | Grant or award · Employee Stock Option (Right to Buy) | +699,100 | 699,100 | ||
| 2021-03-15 | Hogge Gary S. SVP,Clinical & Medical Affairs | Grant or award · Employee Stock Option (Right to Buy) | +419,500 | 419,500 | ||
| 2020-12-31 | Culley Brian M President and CEO | Option exercise | +15,450 | $1.76 | $27K | 190,945 |
| 2020-12-31 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $1.76 | $9K | 185,602 |
| 2020-12-31 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 92,700 |
Page 9 of 17 · 322 trades